Consort Medical plc (LON:CSRT) insider Jonathan Glenn sold 14,908 shares of the firm’s stock in a transaction dated Wednesday, August 14th. The stock was sold at an average price of GBX 726 ($9.49), for a total transaction of £108,232.08 ($141,424.38).
CSRT stock opened at GBX 726 ($9.49) on Monday. The company has a quick ratio of 1.04, a current ratio of 1.63 and a debt-to-equity ratio of 46.56. Consort Medical plc has a fifty-two week low of GBX 700 ($9.15) and a fifty-two week high of GBX 1,270 ($16.59). The firm’s 50-day simple moving average is GBX 788.74 and its 200 day simple moving average is GBX 873.36. The stock has a market cap of $358.38 million and a PE ratio of 34.25.
The company also recently disclosed a dividend, which will be paid on Friday, October 25th. Investors of record on Thursday, September 19th will be issued a GBX 13.80 ($0.18) dividend. This represents a dividend yield of 1.53%. The ex-dividend date is Thursday, September 19th. This is a boost from Consort Medical’s previous dividend of $7.60. Consort Medical’s dividend payout ratio (DPR) is 1.32%.
About Consort Medical
Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products.
Featured Story: What are different types of coverage ratios?
Receive News & Ratings for Consort Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical and related companies with MarketBeat.com's FREE daily email newsletter.